4//SEC Filing
Adaptimmune Therapeutics PLC 4
Accession 0001104659-16-160132
$ADAPCIK 0001621227operating
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:30 PM ET
Size
5.8 KB
Accession
0001104659-16-160132
Insider Transaction Report
Form 4
Kerr Giles Francis Bertram
Director
Transactions
- Award
Option to purchase Ordinary Shares
2016-11-29+288,000→ 288,000 totalExercise: $0.81Exp: 2026-11-29→ Ordinary Shares (288,000 underlying)
Footnotes (2)
- [F1]The exercise price was converted from GBP0.65 based on the closing midpoint exchange rate for the U.S. dollar on the trading day prior to the date of grant listed in the Financial Times. The actual exercise price will be the pounds sterling amount.
- [F2]Exercisable as to 72,000 Ordinary Shares on November 29, 2017 and will be exercisable as to the remainder in monthly installments of 9,000 Ordinary Shares on the twenty-ninth of each month from December 29, 2017 through November 29, 2019.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001621227
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 4:30 PM ET
- Size
- 5.8 KB